Clinical trial
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
NCT02711865 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
- Lead sponsor
- Hillel Yaffe Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2016
- Completion date
- May 31, 2019
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer